
|Articles|September 15, 2022
Characterizing AAVs with SEC-MALS
Author(s)Wyatt Technology Corporation
SEC-MALS is a platform method for effective product and process development, as well as quality control, of AAVs for gene therapy.
SEC-MALS is a platform method for effective product and process development, as well as quality control, of AAVs for gene therapy.